Surendralal Karsanbhai elected to Merck Board of Directors
With the addition of Karsanbhai, the Merck board will consist of 13 members
With the addition of Karsanbhai, the Merck board will consist of 13 members
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Secretary Vaidya Rajesh Kotecha has urged senior officials to strive for the successful attainment of targets during the campaign
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Subscribe To Our Newsletter & Stay Updated